Population stratification may bias analysis of PGC-1α as a modifier of age at Huntington disease motor onset
Open Access
- 25 July 2012
- journal article
- research article
- Published by Springer Nature in Human Genetics
- Vol. 131 (12) , 1833-1840
Abstract
Huntington’s disease (HD) is an inherited neurodegenerative disorder characterized by motor, cognitive and behavioral disturbances, caused by the expansion of a CAG trinucleotide repeat in the HD gene. The CAG allele size is the major determinant of age at onset (AO) of motor symptoms, although the remaining variance in AO is highly heritable. The rs7665116 SNP in PPARGC1A, encoding the mitochondrial regulator PGC-1α, has been reported to be a significant modifier of AO in three European HD cohorts, perhaps due to affected cases from Italy. We attempted to replicate these findings in a large collection of (1,727) HD patient DNA samples of European origin. In the entire cohort, rs7665116 showed a significant effect in the dominant model (p value = 0.008) and the additive model (p value = 0.009). However, when examined by origin, cases of Southern European origin had an increased rs7665116 minor allele frequency (MAF), consistent with this being an ancestry-tagging SNP. The Southern European cases, despite similar mean CAG allele size, had a significantly older mean AO (p < 0.001), suggesting population-dependent phenotype stratification. When the generalized estimating equations models were adjusted for ancestry, the effect of the rs7665116 genotype on AO decreased dramatically. Our results do not support rs7665116 as a modifier of AO of motor symptoms, as we found evidence for a dramatic effect of phenotypic (AO) and genotypic (MAF) stratification among European cohorts that was not considered in previously reported association studies. A significantly older AO in Southern Europe may reflect population differences in genetic or environmental factors that warrant further investigation.Keywords
This publication has 28 references indexed in Scilit:
- CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashionNeurology, 2012
- The gene coding for PGC-1α modifies age at onset in Huntington's DiseaseMolecular Neurodegeneration, 2009
- Adherence to Mediterranean diet and health status: meta-analysisBMJ, 2008
- Correlation between Genetic and Geographic Structure in EuropeCurrent Biology, 2008
- No evidence of association between BDNF gene variants and age-at-onset of Huntington's diseaseNeurobiology of Disease, 2006
- Transcriptional Repression of PGC-1α by Mutant Huntingtin Leads to Mitochondrial Dysfunction and NeurodegenerationCell, 2006
- Genetic analysis of candidate genes modifying the age-at-onset in Huntington’s diseaseHuman Genetics, 2006
- Defects in Adaptive Energy Metabolism with CNS-Linked Hyperactivity in PGC-1α Null MiceCell, 2004
- Peroxisome Proliferator-Activated Receptor-γ Coactivator 1α (PGC-1α): Transcriptional Coactivator and Metabolic RegulatorEndocrine Reviews, 2003
- A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive ThermogenesisCell, 1998